|
Minipress XlDrug - Minipress Xl The trade name of the product as shown on the labeling.
Dosage -
TABLET, EXTENDED RELEASE; ORAL
Active Ingredient(s) -
Prazosin Hydrochloride
Strength -
2.5MG
Applicant -
PFIZER
New Drug Application (NDA) Number -
019775
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Jan 29, 1992
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Pfizer Inc
Minipress Xl
Prazosin Hcl Eq 5mg Base Capsule; Oral
Prazosin Hcl Eq 1mg Base Capsule; Oral Prazosin Hcl Eq 2mg Base Capsule; Oral Prazosin Hcl Eq 5mg Base Capsule; Oral Minipress Xl 2.5mg Tablet, Extended Release; Oral Prazosin Hcl Eq 1mg Base Capsule; Oral Prazosin Hcl Eq 2mg Base Capsule; Oral Prazosin Hcl Eq 5mg Base Capsule; Oral Prazosin Hcl Eq 1mg Base Capsule; Oral Prazosin Hcl Eq 2mg Base Capsule; Oral NewDrugInformation |